Donna Reilly

439 total citations
13 papers, 308 citations indexed

About

Donna Reilly is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Donna Reilly has authored 13 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Donna Reilly's work include Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (7 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Donna Reilly is often cited by papers focused on Asthma and respiratory diseases (10 papers), Respiratory and Cough-Related Research (7 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Donna Reilly collaborates with scholars based in United States, United Kingdom and Canada. Donna Reilly's co-authors include Amanda Emmett, Richard ZuWallack, Katharine Knobil, Donald A. Mahler, Kathleen Rickard, Nina L. Church, Lisa Edwards, Paul Dorinsky, Steven W. Yancey and Steven M. Koenig and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Respiratory Medicine.

In The Last Decade

Donna Reilly

13 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Reilly United States 6 269 243 19 17 16 13 308
Wolfgang Seibold Germany 6 447 1.7× 478 2.0× 24 1.3× 40 2.4× 50 3.1× 15 528
Ferran Chuecos Spain 9 295 1.1× 240 1.0× 11 0.6× 8 0.5× 18 1.1× 20 324
S. Crescioli Italy 8 185 0.7× 186 0.8× 9 0.5× 24 1.4× 43 2.7× 12 313
Niloufar Farzan Netherlands 9 78 0.3× 126 0.5× 4 0.2× 32 1.9× 11 0.7× 13 204
Peter Arvidsson Sweden 10 408 1.5× 476 2.0× 6 0.3× 23 1.4× 87 5.4× 17 519
Li An China 7 72 0.3× 47 0.2× 7 0.4× 10 0.6× 2 0.1× 11 97
Anna Selby United Kingdom 4 54 0.2× 58 0.2× 4 0.2× 3 0.2× 5 0.3× 5 78
J. B. Wilk United States 3 84 0.3× 51 0.2× 20 1.1× 21 1.2× 1 0.1× 3 141
Marc Csete United States 4 53 0.2× 54 0.2× 3 0.2× 6 0.4× 4 0.3× 6 91
Catherine Scott-Wilson United States 7 254 0.9× 214 0.9× 2 0.1× 2 0.1× 3 0.2× 9 266

Countries citing papers authored by Donna Reilly

Since Specialization
Citations

This map shows the geographic impact of Donna Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Reilly more than expected).

Fields of papers citing papers by Donna Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Reilly. The network helps show where Donna Reilly may publish in the future.

Co-authorship network of co-authors of Donna Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Reilly. A scholar is included among the top collaborators of Donna Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Reilly. Donna Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Djukanović, Ratko, Susan J. Wilson, Wendy C. Moore, et al.. (2010). Montelukast added to fluticasone propionate does not alter inflammation or outcomes. Respiratory Medicine. 104(10). 1425–1435. 8 indexed citations
2.
Anderson, Wayne H., Eugene R. Bleecker, Harold S. Nelson, et al.. (2008). Lack of Effect of Promoter, Coding and 3′ Polymorphisms of the β2-adrenergic Receptor (ADRB2) on the Clinical Response to Salmeterol Alone or with Fluticasone Propionate in Subjects with Asthma. Journal of Allergy and Clinical Immunology. 121(2). S143–S143. 2 indexed citations
3.
Bleecker, Eugene R., Harold S. Nelson, Jonathan Corren, et al.. (2008). Arg16Gly Polymorphism of the β2-adrenergic Receptor Gene Does Not Modulate Clinical Response to Salmeterol in Subjects with Asthma. Journal of Allergy and Clinical Immunology. 121(2). S143–S143. 5 indexed citations
4.
Nelson, Harold S., Eugene R. Bleecker, Jonathan Corren, et al.. (2008). Characterization of Asthma Exacerbations by Arg16Gly Genotype in Subjects with Asthma Receiving Salmeterol Alone or with Fluticasone Propionate. Journal of Allergy and Clinical Immunology. 121(2). S131–S131. 2 indexed citations
5.
Jarjour, Nizar N., Susan J. Wilson, Steven M. Koenig, et al.. (2006). Control of airway inflammation maintained at a lower steroid dose with 100/50 μg of fluticasone propionate/salmeterol. Journal of Allergy and Clinical Immunology. 118(1). 44–52. 28 indexed citations
6.
Dorinsky, Paul, Susan J. Wilson, Steve Yancey, et al.. (2005). CONTROL OF AIRWAY INFLAMMATION IS ACHIEVED IN ASTHMA PATIENTS WITH FLUTICASONE PROPIONATE ALONE: ADDING MONTELUKAST PROVIDES NO ADDITIONAL CONTROL OF AIRWAY INFLAMMATION. CHEST Journal. 128(4). 164S–164S. 1 indexed citations
7.
Reilly, Donna, et al.. (2003). Exercise to Exhaustion in the Second-Wind Phase of Exercise In A Case of McArdle's Disease with and without Creatine Supplementation. Scottish Medical Journal. 48(2). 46–48. 7 indexed citations
8.
Koenig, Steven M., John Oppenheimer, Steven A. Sahn, et al.. (2003). Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily. Journal of Allergy and Clinical Immunology. 111(1). 57–65. 60 indexed citations
9.
Dorinsky, Paul, Steve Yancey, Donna Reilly, & Lisa Edwards. (2003). The Effectiveness of Fluticasone Propionate/Salmeterol 100/50mcg Diskus ® (FSC) as an Inhaled Corticosteroid-Sparing Agent: Effect of Baseline Asthma Severit. CHEST Journal. 124(4). 87S–87S. 2 indexed citations
10.
Dorinsky, Paul, Steve Yancey, Donna Reilly, Lisa Edwards, & Kathy Rickard. (2003). Long-term effectiveness of the fluticasone propionate/salmeterol (FSC) 100/50 mcg combination product as an inhaled corticosteroid sparing agent. Journal of Allergy and Clinical Immunology. 111(2). S125–S125. 1 indexed citations
11.
ZuWallack, Richard, Donald A. Mahler, Donna Reilly, et al.. (2001). Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD. CHEST Journal. 119(6). 1661–1670. 176 indexed citations
12.
Wolfe, James, Paul Chervinsky, Michael B. Lawrence, et al.. (2000). Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma. Annals of Allergy Asthma & Immunology. 84(3). 334–340. 15 indexed citations
13.
Reilly, Donna, et al.. (1974). Genotypic variations in Caucasian leukocyte estradiol 16 hydroxylase activity: a measurable determinant of breast cancer risk?. PubMed. 59(5). 151–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026